EverydayHealth

For Doug Bodde, a Laboratory Service and Partner Development Manager in the Department of Laboratory Medicine and Pathology in Rochester, blood donation has been a part of his life since he was young.

A letter of appreciation, which was forwarded to Mayo Clinic President and CEO John Noseworthy, M.D., and Board of Trustees member Samual Di Piazza, Jr., described the outstanding contributions to science and education that Mayo Clinic DLMP physicians and scientists have provided to a variety of renowned publications in the industry.

This week’s Research Roundup highlights how the androgen receptor variant AR-V9 is co-expressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance.

Elissa Hall, Associate Director for Curriculum and Education Technology and an Assistant Professor at Mayo Clinic, discusses how the adoption of social media in education creates a flexible environment for facilitating collaborative, deeper learning by providing an avenue to network and dialogue with an international community.

In 2012, the Journal of Clinical Microbiology began publishing quarterly biographical features of pioneers and innovators in clinical microbiology. Of the more than 15 microbiologists who have been profiled over the years, the career summary of Thomas F. Smith, Ph.D., Emeritus Staff, is unique in that it represents the journal’s first biographical feature primarily focused on a diagnostic virologist.

Useful For Assessing the patient’s probability of having detectable prostate cancer when total prostate specific antigen (PSA) concentrations are between 4–10 ng/mL. Results from a[...]

Diva Salomão, M.D., has been named the Diversity Leader for the Mayo Clinic Department of Laboratory Medicine and Pathology.

Will Laxen, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory, was recently awarded the Mayo Clinic Individual Award for Service Excellence for his continuous commitment to quality and service.

Justin Kreuter, M.D., discusses the importance of identifying the "blind spots" in your career and shares some of his own experiences from a patient blood-management conference.

This week’s Research Roundup highlights how AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.

European Heart Journal recently highlighted Mayo Clinic's new blood test that may predict cardiovascular events in patients with or without coronary artery disease.

We wrapped up another fun National Medical Laboratory Professional’s Week with a door-decorating contest, weekly quizzes, and, of course, treats. This year’s theme was, “All-Stars Laboratory Team: Teaming up for Patient Care.” We ended up with 20 door submissions this year, which made for a very close competition. There are SO many creative staff members at Mayo Medical Laboratories. View this post to see the submissions and winner.

Some early-stage cancers are missed by conventional screening and are only detected when symptoms occur. Mayo Clinic is collaborating with Grail, a life science company, and Sutter Health of California, on the STRIVE clinical research study to facilitate the development of Grail’s blood tests for early-stage cancer detection.